Types of Heart Blocks
First Degree
Second Degree (Type 1 Mobitz)
Second Degree (Type 2)
Third Degree
First Degree Heart Block
Second Degree, Type 1 (Mobitz) Heart Block
Second Degree, Type 2 Heart Block
Third Degree
Treatment of Heart Block
Normal ECG waveform
P wave
PR interval
QRS
P wave < 0.10
PR = 0.12 - 0.20
QRS = < 0.12
ST depression or elevation > 0.5mm is a concern
Total Cholesterol
This is the sum of HDL, LDL and VLDL
Desirable levels are >200mg/dL (<5.2mmol/L)
HDL (high-density lipoprotein)
“Good cholesterol”
Binds with fat from the body in the bloodstream and carries it to the liver
May confer anti inflammatory and antioxidant benefits on the arterial wall (Barter, 2004)
HDL levels are generally higher in women
Exercise and smoking cessation can help raise HDL levels (Scruth & Haynes, 2011)
Desirable level >40mg/dL (<1.00mmol/L)
LDL (low-density lipoprotein)
“Bad cholesterol”
Carries fat from the liver to other parts of the body
High levels are associated with increased risk of coronary artery disease, peripheral artery disease and stroke.
Desirable level <2.00mmol/L)
VLDL: (very low-density lipoprotein)
Primary carrier of triglycerides in the blood
Distributes the triglycerides produced by the liver, then is reduced to LDL
Not usually mentioned during routine cholesterol screening, as there is no direct way to measure it. Its value is estimated as a percentage of the triglyceride level.
Desirable level <1.67mmol/L)
Triglycerides
Carried by VLDL
High triglyceride level along with a high LDL cholesterol increases risk for CAD more than having a high LDL cholesterol level alone.
Desirable level <1.7mmol/L)
Antihypertensive medications
diuretics, beta-blockers ACE inhibitors, angiotensin II receptor blockers Calcium antagonists
SAMPLE history
Signs and Symptoms
Allergies
Medications
Past medical history, injuries, illnesses
Last meal/intake
Events leading up to the injury and/or illness
CARDIAC history
Chest pain Ankle swilling Reduced exercise tolerance Dysnpoea, orthopnea Irregular heart beat and palpitations Altered colour of lips or cyanosis Conciousness reduced or LOC
PQRST
Preceding events Quality Radiating Severity Time
Cardiac enzymes
Creatine kinase (CK),
Creatine kinase–myocardial band isofraction (CK-MB), Troponin I
Troponinin II
S/S of MI
Sudden chest pain or discomfort, palpitations
Heart sound may include S3 , S4
Tachycardia, bradycardia, or dysrhythmias
Shortness of breath, dyspnea, tachypnea,
Nausea and vomiting; Indigestion
Anxiety, restlessness, light-headedness
Cool, pale, and moist skin
Patient history of presenting symptoms and previous illnesses, and family history of heart
Pharmacology for MI
fibirinolytic therapy: alteplase, reteplase, or tenecteplase, as fibrinolytic therapy,
infusion of heparin or enoxaparin, as antithrombotic therapy to prevent rethrombosis,
clopidogrel to inhibit platelet aggregation
beta-blocker to prevent ventricular arrhythmias and ischemia;
nitroglycerin for angina;
atorvastatin to reduce cholesterol levels;
alprazolam for anxiety; and
morphine sulfate for pain